Missouri Telehealth Prescribing: Establishing a Valid Provider-Patient Relationship

Telehealth has rapidly transformed healthcare delivery, offering unprecedented access to care. However, the ability to prescribe medications via telehealth is contingent upon the proper establishment of a valid provider-patient relationship. In Missouri, like many other states, specific statutes and administrative rules govern how this relationship must be formed, particularly when prescribing legend drugs or controlled substances. Healthcare businesses operating in or expanding into Missouri via telehealth must meticulously understand and adhere to these regulations to ensure compliance and avoid significant legal and regulatory repercussions.

Understanding Missouri's Telehealth Framework

Missouri's primary telehealth statute is Missouri Revised Statutes § 191.1145, which defines telehealth and sets the parameters for its use. The statute broadly defines "telehealth" as the use of electronic information and communication technologies to provide health care services, including diagnosis, consultation, treatment, education, care management, and self-management, over a distance. It specifies that telehealth services must be delivered by a healthcare provider acting within the scope of their license.

Crucially, § 191.1145 states that a healthcare provider may provide telehealth services to a patient located in Missouri if the provider is licensed, registered, or certified to provide the same healthcare services in Missouri. This foundational requirement ensures that out-of-state providers must be properly licensed in Missouri to treat Missouri residents via telehealth.

Establishing the Provider-Patient Relationship

The core of telehealth prescribing lies in the establishment of a valid provider-patient relationship. Missouri law generally permits this relationship to be established through telehealth, provided certain conditions are met. The Missouri Board of Registration for the Healing Arts (MOBRHA), which licenses physicians and surgeons, has further clarified these requirements through its administrative rules, specifically 20 CSR 2150-2.100, "Telehealth Services."

According to these rules, a physician-patient relationship may be established through telehealth, but it must include:

• Patient identification: Verifying the identity of the patient receiving services.
• Informed consent: Obtaining the patient's consent for telehealth services.
• Medical history: Obtaining a medical history of the patient.
• Physical examination: Performing a physical examination of the patient appropriate for the patient's condition and the standard of care. This is a critical point, as the rule emphasizes that the technology used must allow for an examination equivalent to an in-person encounter to meet the standard of care.
• Documentation: Maintaining appropriate medical records.

The rules emphasize that the standard of care for telehealth services is the same as the standard of care for in-person services. This means that providers must exercise the same level of care, skill, and treatment in a telehealth encounter as they would in a traditional face-to-face setting.

Prescribing Medications via Telehealth

Once a valid provider-patient relationship is established, Missouri law permits prescribing medications via telehealth, subject to certain limitations, especially concerning controlled substances.

Non-Controlled Substances

For non-controlled substances, a prescription can generally be issued following a telehealth encounter where a valid provider-patient relationship has been established, and the provider has conducted an appropriate evaluation. The key is that the telehealth interaction must be sufficient to meet the standard of care for diagnosing the patient's condition and determining the appropriate treatment, including medication.

Controlled Substances

Prescribing controlled substances via telehealth is subject to stricter regulations, largely influenced by federal law, specifically the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. This federal law generally requires an in-person medical evaluation before a practitioner can prescribe a controlled substance to a patient, with certain exceptions.

Missouri's regulations align with the Ryan Haight Act. While the state has allowed for some flexibility during public health emergencies (such as the COVID-19 pandemic), the default rule for controlled substances typically requires an initial in-person examination or a qualifying telehealth evaluation under specific, limited circumstances defined by federal and state waivers or exceptions. The Missouri Board of Pharmacy also plays a role in regulating controlled substance dispensing, reinforcing the need for legitimate prescriptions based on a valid patient relationship.

Key considerations for controlled substance prescribing via telehealth in Missouri:

• Federal Waivers: During the COVID-19 Public Health Emergency, the DEA issued waivers to the in-person exam requirement of the Ryan Haight Act, allowing practitioners to prescribe controlled substances via telehealth without a prior in-person medical evaluation. However, these waivers are temporary and subject to change or expiration. Providers must stay informed about the current status of federal waivers.
• Telehealth Modalities: For controlled substances, the telehealth encounter must typically be synchronous, interactive audio-visual communication to facilitate a thorough evaluation. Asynchronous methods are generally insufficient for establishing the necessary relationship for controlled substance prescribing.
• Standard of Care: Even with waivers, the prescribing of controlled substances via telehealth must meet the same standard of care as an in-person encounter, including a comprehensive assessment of the patient's medical history, current medications, and potential for abuse or diversion.

Documentation Requirements

Thorough documentation is critical for all telehealth services, especially those involving prescribing. Providers must maintain comprehensive medical records that include:

• The patient's identity and location during the telehealth encounter.
• The date and time of the service.
• The type of technology used (e.g., synchronous audio-visual).
• A detailed medical history and physical examination findings (as appropriate for the modality).
• Diagnosis, treatment plan, and rationale for prescribing.
• Informed consent for telehealth services.
• Any referrals made.

Adequate documentation serves as proof that a valid provider-patient relationship was established and that the standard of care was met, which is essential for defending against potential regulatory inquiries or malpractice claims.

Impact on Specific Specialties

• Weight-Loss and Hormone Therapy: These specialties often involve prescribing controlled substances (e.g., phentermine for weight loss) or other legend drugs. Providers must be particularly diligent in establishing a valid relationship, conducting thorough evaluations, and adhering to controlled substance prescribing rules.
• Mental Health: Prescribing psychiatric medications, including controlled substances like benzodiazepines or stimulants, via telehealth requires strict adherence to the Ryan Haight Act and Missouri's rules. Comprehensive initial assessments and ongoing monitoring are essential.
• Dermatology and Medspas: While many dermatological prescriptions are non-controlled, some conditions might require medications with stricter oversight. Medspas offering services that involve prescribing must ensure their medical directors and prescribing practitioners comply with all telehealth relationship and prescribing requirements.
• Primary Care and Urgent Care: These practices are at the forefront of telehealth adoption and must ensure all prescribing, whether for acute conditions or chronic disease management, follows the established guidelines for a valid provider-patient relationship.

Conclusion

Missouri has established a clear regulatory framework for telehealth, emphasizing the importance of a valid provider-patient relationship as the foundation for prescribing. Healthcare businesses leveraging telehealth in Missouri must prioritize compliance with Missouri Revised Statutes § 191.1145 and 20 CSR 2150-2.100. This includes ensuring proper patient identification, obtaining informed consent, conducting appropriate evaluations via suitable technology, and maintaining meticulous documentation. For controlled substances, federal and state regulations demand even greater scrutiny, often requiring an in-person component or operating under specific, temporary waivers. Proactive understanding and adherence to these regulations are crucial for mitigating risk and ensuring the safe and effective delivery of telehealth services in Missouri.

---